In a xenograft tumor model, abrogation of TGFβ signaling led to increased colon cancer cell proliferation, decreased apoptosis and enhanced tumor growth in vivo, associated with elevated expression and activation of IRS-1. This evidence concerns the gene TGFB1 and colonic neoplasm.